| Literature DB >> 33556169 |
Jun-Qiang Yin1,2, Yi-Wei Fu1, Zhen-Hua Gao3, Chang-Ye Zou1, Xian-Biao Xie1, Bo Wang1, Zhi-Hai Zhong4, Gang Huang1, Jing-Nan Shen1,2.
Abstract
BACKGROUND: More effective therapies are needed to treat progressive desmoid tumors when active surveillance and systemic therapy fail.Entities:
Keywords: Desmoid tumor; Local recurrence; Sandwich isolation surgery
Mesh:
Year: 2021 PMID: 33556169 PMCID: PMC8117464 DOI: 10.1093/neuros/nyaa589
Source DB: PubMed Journal: Neurosurgery ISSN: 0148-396X Impact factor: 4.654
FIGURE 1.Patient flow diagram.
FIGURE 2.Images illustrating sandwich isolation surgery. A and B, a desmoid tumor invading adjacent nerves and vessels. C and D, resect the tumor as completely as possible by the wide resection of peripheral muscles in non-neurovasculature-involving regions (R0 resection) and perform R2 resection in neurovasculature-involving regions to preserve adjacent blood vessels and nerves and then envelop involved neurovascular structures with a polyester cardiovascular patch. E and F, polyester cardiovascular patch is sutured in place to isolate the involved neurovascular bundle from normal tissue.
Clinical Characteristics and Outcomes of the Patients Who Received Sandwich Isolation Surgery
| Case | Age (year) | Sex | Disease | Number of previous surgeries | Time between previous surgeries and recurrences (months) | Tumor site | Involved nerves and vessels, and relation with tumor | Radiotherapy or chemotherapy before surgery | Radiotherapy or chemotherapy after surgery | Follow-up (months) | Progression or local recurrence after sandwich isolation surgery |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 10 | Female | Recurrent | 2 | 29, 6 | Right thigh | Sciatic nerve, surrounded | None | None | 63.6 | No |
| 2 | 23 | Female | Recurrent | 1 | 5 | Left thigh | Sciatic nerve, surrounded | None | None | 62.4 | Progression, 11.5 mo after surgery |
| 3 | 9 | Male | Recurrent | 3 | 6, 12, 29 | Left upper arm | Axillary vessels and nerves, partly involved | Chemotherapy times 7 | Chemotherapy times 4 | 48.5 | No |
| 4 | 17 | Male | Recurrent | 1 | 6 | Left gluteal region | Sciatic nerve, partly involved | None | None | 51.6 | No |
| 5 | 27 | Male | Recurrent | 1 | 9 | Right forearm | Interosseous vessels and nerves, ulnar vessels, and nerves, partly involved | None | Radiotherapy | 32.2 | No |
| 6 | 51 | Male | Primary | 0 | None | Right shoulder | Axillary vessels and nerves, partly involved | None | None | 31.3 | No |
| 7 | 22 | Female | Primary | 0 | None | Right shoulder | Axillary vessels and nerves, partly involved | None | Radiotherapy | 37.4 | No |
| 8 | 2 | Male | Recurrent | 1 | 2 | Right upper arm | Axillary vessels and nerves, partly involved | Chemotherapy times 3 | None | 24.8 | No |
| 9 | 39 | Female | Recurrent | 1 | 24 | Right gluteal region | Sciatic nerve, surrounded | None | None | 22.5 | No |
| 10 | 55 | Male | Primary | 0 | None | Right gluteal region | Sciatic nerve, partly involved | None | None | 16.7 | No |
| 11 | 59 | Male | Primary | 0 | None | Left leg | Common peroneal nerve, surrounded | None | None | 19.0 | No |
| 12 | 16 | Female | Recurrent | 1 | 12 | Left thigh | Sciatic nerve, surrounded | None | None | 15.8 | Local recurrence, 9.6 mo after surgery |
| 13 | 47 | Female | Recurrent | 1 | 24 | Left thigh | Popliteal vessels and sciatic nerve, partly involved | None | None | 15.2 | Local recurrence, 9.5 mo after surgery |
FIGURE 3.A 23-yr-old female (case 2 from Table 1) with a twice-recurrent progressive desmoid tumor located at the posterior left thigh, 5 mo after the previous surgery. A, preoperative MRI showed the sciatic nerve (yellow arrow) adhered to but was not involved by the proximal part of recurrent tumor (white asterisk) and was surrounded by the distal part of recurrent tumor (white asterisk). B, some of residual tumors on the sciatic nerve were observed (white circle). C, the biomaterial patch enclosed the sciatic nerve and isolated the sciatic nerve with residual tumors from the surrounding normal tissue. At the bifurcation of the tibial and common peroneal nerves (white arrow), part of the sciatic nerve with residual tumors was not enclosed. D, MRI showed local recurrence (black asterisk) at 11.5 mo after surgery. Of note, no recurrence of the tumor was seen in the area of the sciatic nerve that was isolated by the biomaterial patch (yellow arrow).
Characteristics of Patients Who Received Sandwich Isolation and Traditional Surgery
| Sandwich isolation surgery | Traditional surgery | χ2 |
| |
|---|---|---|---|---|
| Age (year) | ||||
| <25 | 7 (54) | 11 (61) | 1.854 | .236 |
| ≥25 | 6 (46) | 3 (39) | ||
| Sex | ||||
| Male | 7 (54) | 3 (21) | 3.038 | .120 |
| Female | 6 (46) | 11 (79) | ||
| Disease | ||||
| Primary | 4 (31) | 3 (21) | 0.306 | .678 |
| Recurrent | 9 (69) | 11 (79) | ||
| Limb localization | ||||
| Girdle | 5 (39) | 6 (43) | 0.345 | 1.000 |
| Proximal | 6 (46) | 5 (36) | ||
| Distal | 2 (15) | 3 (21) | ||
| Tumor size | ||||
| ≤10 cm | 7 (54) | 5 (36) | 0.898 | .449 |
| >10 cm | 6 (46) | 9 (64) | ||
| Nerves or vessels involved | ||||
| Surrounded | 5 (38) | 4 (29) | 0.297 | .695 |
| Partly involved | 8 (62) | 10 (71) | ||
| Received chemotherapy | ||||
| Yes | 2 (15) | 1 (7) | 0.464 | .596 |
| No | 11 (85) | 13 (93) | ||
| Received radiotherapy | ||||
| Yes | 2 (15) | 3 (21) | 0.163 | 1.000 |
| No | 11 (85) | 11 (79) | ||
| Neurovasculature margin | ||||
| R0 | 0 (0) | 2 (14) | 3.602 | .098 |
| R1 | 0 (0) | 2 (14) | ||
| R2 | 13 (100) | 10 (71) | ||
| Non-neurovasculature margin | ||||
| R0 | 11 (85) | 10 (71) | 1.194 | .789 |
| R1 | 1 (8) | 3 (21) | ||
| R2 | 1 (8) | 1 (7) |
Data are presented as number (percentage).
FIGURE 4.Kaplan-Meier curves for EFS of sandwich isolation surgery and traditional surgery. The estimated 3-yr EFS rate was 76.9% for patients who received sandwich isolation surgery and 32.7% for patients who received traditional surgery (P = .025), with a median duration of follow-up of approximately 34 mo (IQR: 22.5-48.8 mo).
Analysis of Progression and Local Recurrence after Sandwich Isolation Surgery
| Case[ | Margin status of neurovasculature-involving region | Margin status of non-neurovasculature-involving region | Location of progression or local recurrence | Progression or local recurrence in isolated neurovasculature-involving region | EFS (months) |
|---|---|---|---|---|---|
| 2 | R2, not fully isolated | R0 | Non-isolated neurovasculature-involving region | None | 11.5 |
| 12 | R2 | R1 | Non-neurovasculature involving region | None | 9.6 |
| 13 | R2 | R2 | Non-neurovasculature involving region | None | 9.5 |
aCase numbers in concordance with Table 1.